OSIMERTINIB | OSIMERTINIB | ATC L01EB04
ANTINEOPLASTIC COVALENT KINASE INHIBITOR TREATMENT OF METASTATIC EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) T790M MUTATION POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) ALSO INHIBITED THE ACTIVITY OF HER2, HER3, HER4, ACK1 AND BLK | ORAL | Tmax 6 HOUR VD 986 LITER Cl 14.2 LITER / HOUR HT 48 HOUR | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PDB 4ZAU (AZD9291 COMPLEX WITH WILD TYPE EGFR) LIGAND CODE = YY3 (link to the list of PDB complexes) Download experimental 3D coordinates of YY3 with added hydrogens | Epidermal growth factor receptor UNIPROT P00533 EGFR more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |